Genetic Toxicity of Methamphetamine In Vitro and in Human Abusers

Environmental and Molecular Mutagenesis

Volumn 42, Issue 4, 2003, Pages 233-242

  Li, Jih Heng ^a,b   Hu, Heng Cheng ^b   Chen, Wei Bang ^b   Lin, Shih Ku ^c  

^a Executive Yuan   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

Author keywords

Genotoxicity; Hprt mutation; Human abuser; Methamphetamine; Micronucleus assay; Reactive oxygen species; Sister chromatid exchange

Indexed keywords

DRUG METABOLITE; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; EXPOSURE; GENOTOXICITY; IN VITRO STUDY; LYMPHOCYTE; MALE; MICRONUCLEUS; MUTANT; NEUROTOXICITY; NONHUMAN; RAT; SALMONELLA TYPHIMURIUM; SISTER CHROMATID EXCHANGE;

ADULT; ANIMALS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LIVER; LYMPHOCYTES; MALE; METHAMPHETAMINE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTATION; RATS; REACTIVE OXYGEN SPECIES; SALMONELLA TYPHIMURIUM; SISTER CHROMATID EXCHANGE; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

CRICETINAE; CRICETULUS GRISEUS; LETHRINIDAE; SALMONELLA TYPHIMURIUM;

EID: 0346098200     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10198     Document Type: Article

References (52)

1. Amarose AP, Schuster CR, Muller TP. 1973. An animal model for the evaluation of drug-induced chromosome damage. Oncology 27: 550-562.
2. Ames BN. 1974. A combined bacterial and liver test system for detection and classification of carcinogens and mutagens. Genetics 78:91-95.
3. Ames BN, Durston WE, Yamasaki E, Lee FD. 1973. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70:2281-2285.
4. Ames BN, McCann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347-364.
5. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. 2000. History of the methamphetamine problem. J Psychoactive Drugs 32:137-141.
6. Anwar WA, Au WW, Legator MS, Sadagopa, Ramanujam VM. 1989. Effect of dimethyl sulfoxide on the genotoxicity and metabolism of benzene in vivo. Carcinogenesis 10:441-445.
7. Beebe DK, Walley E, 1995. Smokable methamphetamine (Ice): an old drug in a different form. Am Fam Physician 51:449-453.
8. Cadet JL, Brannock C. 1998. Invited review: free radicals and the pathobiology of brain doparnine systems. Neurochem Int 32:117-131.
9. 14C] methamphetamine in man, the guinea pig and the rat. Biochem J 129:11-22.
10. Chang CC, Castellazzi M, Glover TW, Trosko JE. 1978. Effects of harmon and nonharmon on spontaneous and ultraviolet light-induced mutagenesis in cultured Chinese hamster cells. Cancer Res 38:4527-4533.
11. CNN. 2003. Shepperd: "Go-pills" common for pilots. January 3, 2003 (http:/www.cnn.com/2003/US/01/03/cnna.shepperd/index.html).
12. Deng X, Cadet JL. 1999. Methamphetamine administration causes over-expression of nNOS in the mouse striatum. Brain Res 851:254-257.
13. Dixon SD, Bejar R. 1989. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 115:770-778.
14. Dobo KL, Eastmond DA. 1994. Role of oxygen radicals in the chromosomal loss and breakage induced by the quinone-forming compounds, hydroquinone and tert-butylhydroquinone. Environ Mol Mutagen 24:293-300.
15. Elwell JH, Siim BG, Evans JW, Brown JM. 1997. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity. Biochem Pharmacol 54:249-257.
16. Esterbauer H, Eckl P, Ortner A. 1990. Possible mutagens derived from lipids and lipid precursors. Mutat Res 238:223-233.
17. Fenech M. 1993. The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environ Health Perspect 101(suppl 3):101-107.
18. Feng MR, Loo J, Wright J. 1998. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling. Drug Metab Dispos 26:982-988.
19. Hassoun EA, Stohs SJ. 1996. TCDD, endrin and lindane induced oxidative stress in fetal and placental tissues of C57BL/6J and DBA/2J mice. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115:11-18.
20. Hirata H, Ladenheim B, Carlson E, Epstein C, Cadet JL. 1996. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 714:95-103.
21. Hiroi T, Imaoka S, Chow T, Funae Y. 1998. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Biochim Biophys Acta 1380:305-312.
22. Hsie AW, Xu ZD, Yu YJ, Sognier MA, Hrelia P. 1990. Molecular analysis of reactive oxygen-species-induced mammalian gene mutation. Teratog Carcinog Mutagen 10:115-124.
23. International Narcotics Control Board. 2003. Report of the INCB for 2002. New York: United Nations.
24. Itzhak Y, Gandia C, Huang PL, Ali SF. 1998. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Pharmacol 284:1040-1047.
25. Jayanthi S, Ladenheim B, Cadet JL. 1998. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/ zinc-superoxide dismutase transgenic mice. Ann NY Acad Sci 844:92-102.
26. 6 CHO-K1cells were enzo-[a]pyrene. Cancer Res 56:1526-1532.
27. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Lorge E, Norppa H, Surralles J, von der Hude W, Wakata A. 2000. Report from the In Vitro Micronucleus Assay Working Group. Environ Mol Mutagen 35:167-172.
28. Larez A, Briceno E, Ochoa Y, Montenegro M, Aponte N. 1979. Mutagenicity obtained experimentally by oral administration of dextroamphetamine sulfate to the rat. Bull Narc 31:67-70.
29. Lee TC, Huang RY, Jan KY. 1986. Sodium arsenite enhances the cytotoxicity, clastogenicity and 6-thioguanine resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat Res 148:83-89.
30. Li JH, Lin LF. 1998. Genetic toxicology of abused drugs: a brief review. Mutagenesis 13:557-565.
31. Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK. 1997. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 25:1059-1064.
32. Little BB, Snell LM, Gilstrap LC III. 1988. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 72: 541-544.
33. Maron DM, Ames BN. 1983. Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173-215.
34. NBCD. 2003. Drug abuse statistics (from January 1, 1998 through December 31, 2002) [in Chinese]. Taiwan: National Bureau of Controlled Drugs, US Department of Health.
35. Ogura H, Takeuchi T, Morimoto K. 1996. A comparison of the 8-hydroxyde-oxyguanosine, chromosome aberrations and micronucleus techniques for the assessment of the genotoxicity of mercury compounds in human blood lymphocytes. Mutat Res 340:175-182.
36. Phillips BJ, Carroll PA, Tee AC, Anderson D. 1989. Microsome-mediated clastogenicity of butylated hydroxyanisole (BHA) in cultured Chinese hamster ovary cells: the possible role of reactive oxygen species. Mutat Res 214:105-114.
37. Oro AS, Dixon SD. 1987. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 111:571-578.
38. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. 1986. Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 77:1312-1320.
39. Seiden LS, Kleven MS 1989. Methamphetamine and related drugs: toxicity and resulting behavioral changes in responses to pharmacological probes. In: Asghar K, Souza ED, editors. Pharmacology and toxicology of amphetamine and related designer drugs. NIDA Research Monograph 94. National Institute on Drug Abuse. Rockville, MD: US Department of Health and Human Services. p146-160.
40. Sheng P, Cerruti C, Ali S, Cadet JL. 1996. Nitric oxide is a mediator of methamphetamine(METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells. Ann NY Acad Sci 801:174-186.
41. Shick JFE. 1997. Stimulant abuse and dependence. Centre for Drug Research. Minden, Pulau Pinang, Malaysia: Universiti Sains Malaysia.
42. Shimazu H, Takemura N, Ando H, Morita M, Machida K. 1983. Mutagenic activity of N-nitrosomethamphetamine and N-nitrosoephedrine. Cancer Lett 21:63-68.
43. Soper KA, Stolley PD, Gallowat SM, Smith JG, Nichold WW, Wolman SR. 1984. Sister chromatid exchanges: a reexamination of the evidence for sex and race differences in humans. Environ Mutagen 129:77-88.
44. Surridge JF. 1972. Genetic effects of amphetamine salt feeding in Drosophila. Clin Toxicol 5:395-403.
45. Takeuchi T, Nakajima M, Morimoto K. 1996. Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis 17: 1543-1548.
46. Teoule R, Duplaa AM. 1989. Free radical and radiation-induced DNA damage to oligonucleotides. Free Radic Res Commun 6:121-122.
47. United Nations Office for Drug Control and Crime Prevention. 2002. Activities, methods and future opportunities. Global Workshop on Drug Information Systems, December 3-5, 2001, Vienna International Centre, Austria, United Nations.
48. Wang TS, Huang H. 1994. Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis 9:253-257.
49. Winn LM, Wells PG. 1995. Phenytoin-initiated DNA oxidation in murine embryo culture and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol Pharmacol 48:112-120.
50. Youssefi AA, Arutyunyan R, Emerit I. 1994. Chromosome damage in PUVA-treated human lymphocytes is related to active oxygen species and clastogenic factors. Mutat Res 309:185-191.
51. Yu RC, Lee TC, Wang TC, Li JH. 1999. Genetic toxicity of cocaine. Carcinogenesis 20:1193-1199.
52. Yu Y, Xu Z, Hsie AW. 1994. Adriamycin induces large deletions as a major type of mutation in CHO cells. Mutat Res 325:91-98.